Bulletin
Investor Alert

New York Markets Open in:

23andMe Holding Co.

NAS: ME

GO
/marketstate/country/us

Before the Bell

 --Quotes are delayed by 20 min

Jun 8, 2023, 7:17 a.m.

ME
/zigman2/quotes/222659849/composite

$

2.06

Change

+0.06 +3.00%

Volume

Volume 976

Quotes are delayed by 20 min

/zigman2/quotes/222659849/composite

Previous close

$ 2.00

$ 2.00

Change

-0.06 -2.91%

Day low

Day high

$1.98

$2.11

Open

52 week low

52 week high

$1.74

$6.31

Open
Sorry, there are no transactions available for this individual.

Officers and Executives

Ms. Anne E. Wojcicki
President, Chief Executive Officer & Director
Mr. Joseph Selsavage
Chief Financial & Accounting Officer
Mr. David Baker
Chief Security Officer & VP-Engineering
Mr. Steve Lemon
Executive Advisor
Dr. Joyce Tung
Vice President-Research
Dr. L. Okey Onyejekwe
VP-Healthcare Operations & Medical Affairs
Dr. Joseph R. Arron
Chief Scientific Officer
Ms. Kathy L. Hibbs
Secretary & Chief Administrative Officer
Mr. Reza Afkhami
Chief Corporate Development Officer
Dr. Kenneth J. Hillan
Chief Therapeutics Officer
Mr. Adam Auton
Vice President-Human Genetics
Dr. Arnab Chowdry
Vice President-Genetic Technology
Mr. Kent Hillyer
Vice President-Customer Care
Dr. Jennifer Low
Head-Therapeutics Development
Mr. Mike Polcari
Vice President & Chief Architect
Dr. William Richards
Vice President-Drug Discovery
Dr. Monica Viziano
VP-Portfolio Strategy & Alliance Management
Mr. Paul Johnson
Chief Operating Officer-Consumer
Mr. Daniel Chu
Chief Product Officer
Mr. Evan M. Lovell
Director
Dr. Richard H. Scheller
Director
Ms. Savita Pillai
Vice President-People
Ms. Jacquie Cooke Haggarty
General Counsel & Privacy Officer
Mr. Roelof Frederik Botha
Independent Director
Mr. Patrick Shuao-Fong Chung
Independent Director
Mr. Peter J. Taylor
Independent Director
Dr. Valerie C. Montgomery Rice
Independent Director
Dr. Sandra Rae Hernández
Independent Director
Mr. Neal Mohan
Independent Director
Link to MarketWatch's Slice.